Philip Hewitt

Company: Merck

Job title: Global Head of Early Investigative Toxicology

Seminars:

Harnessing Bioconvergence Including Validated MPS Data to Help Transform Drug Discovery & Development While Reducing Reliance on Animal Testing 2:45 pm

Utilizing bioconvergence to develop standardized methods for characterizing microphysiological systems, ensuring consistency and reliability across studies Leveraging bioconvergence to empower prediction modeling in drug discovery Collaborating with different functions to make the best out of the data outputs from thisRead more

day: Day 2